Javascript is not enabled.

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again.

Skip to content
Content starts here
CLOSE ×
Search
CLOSE ×
Search
Leaving AARP.org Website

You are now leaving AARP.org and going to a website that is not operated by AARP. A different privacy policy and terms of service will apply.

1:26

Rx Negotiations Continue, Health Care Costs Concerns

For the week of May 22, 2026: The Supreme Court has declined to hear a challenge to Medicare drug price negotiations, and women worry more about health care costs than developing heart disease, cancer and Alzheimer’s.

Key takeaways

  • Preserve Medicare drug price negotiations to deliver billions in savings for enrollees.
  • Lower drug costs through negotiation to make health care more affordable for millions.
  • Address health care expenses to reduce financial stress and improve preventive care access.

Summary

Medicare drug price negotiations continue to advance following a recent Supreme Court decision that upheld the government’s ability to negotiate lower costs for Medicare recipients. This ruling preserves a program supported by AARP that has already delivered savings of $1.5 billion in out-of-pocket expenses for enrollees on the first 10 medications. Lowering drug prices through negotiation is a crucial step toward making health care more affordable for millions of Americans relying on Medicare.

In related health care news, new research reveals that women are more concerned about paying for health care than the risks of developing heart disease, cancer or Alzheimer’s. Financial stress also causes many to skip preventive care, which experts warn can negatively affect brain health by disrupting sleep, exercise and social connections. Addressing health care costs and access remains vital for improving overall health outcomes and quality of life.

The key takeaways and summary were created with the assistance of generative AI. An AARP editor reviewed and refined the content for accuracy and clarity.

Full Transcript:

[00:00:03] The government can keep negotiating lower drug prices for Medicare recipients, thanks to a Supreme Court decision.

[00:00:10] The justices declined to hear a challenge from drug makers, keeping in place the program that AARP has backed.

[00:00:17] The lower prices for the first 10 medications took effect this year, and enrollees are expected to save $1.5 billion in out-of-pocket

[00:00:26] expenses from those drugs alone. In other Medicare news, rules for brokers and agents are being relaxed

[00:00:33] ahead of this year’s open enrollment. Among the changes, certain disclaimers that describe coverage options won’t

[00:00:40] be required during sales calls, and Medicare Advantage enrollees won’t get mid-year updates on unused benefits.

[00:00:47] Officials say the updates align with federal policy, but some experts worry they could create confusion for beneficiaries.

[00:00:55] A new report shows women worry more about paying for health care than they do about developing Alzheimer’s, heart disease or cancer.

[00:01:04] Those under financial strain are also more likely to skip preventive care. Experts say chronic stress tied to money and caregiving can disrupt

[00:01:12] sleep, exercise and social connection, all key factors for brain health.

Unlock Access to AARP Members Edition

Join AARP to Continue

Already a Member?